In a strange ruling by the Court of Appeals for the Federal Circuit, on July 29, 2019, although publicly released on August 9, 2019, in Genetic Veterinary Scis., Inc. v. Laboklin GmbH & Co KG, the...
On June 25, 2019, the Court of Appeals for the Federal Circuit handed down CellSpin Soft, Inc. v. Fitbit, Inc., in what is an important case dealing with patent-eligibility under 35 U.S.C. §101,...
What had opened with a promise of clarity for patent subject matter eligibility under 35 U.S.C. §101 took a detour with the ChargePoint, Inc. v. SemaConnect, Inc., decision issued on March 28 2019,...
The third treatment method case in the last year that was challenged as patent-ineligible subject matter under 35 U.S.C. §101 has been found eligible by the Court of Appeals for the Federal Circuit,...
On April 17, 2019, Judge William J. Martinez denied an early motion for partial summary judgment for invalidity based patent-ineligible subject matter under 35 U.S.C. §101, in the first federal...
On March 20, 2019, the Court of Appeals for the Federal Circuit ruled in SRI Int’l, Inc. v. Cisco Sys., Inc., in which claims directed to network intrusion were found patent-eligible under 35 U.S.C....
In its second patent-eligibility ruling in a few weeks, the Court of Appeals for the Federal Circuit decided Natural Alts. Int’l, Inc. v. Creative Compounds, LLC, on March 15, 2019, in which it found...
In one of the more fascinating legal analyses presented in recent memory, the Court of Appeals for the Federal Circuit handed down Univ. of Florida Res. Foundation, Inc. v. General Electric Co., on...
Medical diagnostics patents involving a certain lab testing company named Mayo took a hit when those patents were deemed invalid under 35 U.S.C. §101. No, it’s not that Mayo case, but the one in...
The Court of Appeals for the Federal Circuit, on the last day of the court’s calendar year, December 28, 2018, ruled on In re Marco Guldenaar Holding B.V., in what is the last 2018 case discussing...